Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-04-02

Clinical Trial Update: Investigation of Growth Hormone and Platelet-Rich Plasma on Joint Health [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial is investigating growth hormone and platelet-rich plasma for ankle and knee arthritis in Phase 2/3. The study status is NOT_YET_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Growth Hormone (somatropin)
  • Platelet-rich plasma (platelet-rich plasma)

Snippet

Sponsor: Integrant Pty Ltd | Conditions: Arthritis Ankle, Arthritis Knee | Phase 2, Phase 3 | Status: NOT_YET_RECRUITING